Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease

Annals of Oncology

Volumn 7, Issue 9, 1996, Pages 913-918

  Haraf, D J ^a   Weichselbaum, R R ^a   Yokes, E E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

head and neck neoplasms; re irradiation; recurrence; survival

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; PRIORITY JOURNAL; SURVIVAL;

EID: 0030454011     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010793     Document Type: Article

References (36)

1. Wingo PA, Tong T, Belden S. Cancer Statistics, 1995. CA 1995; 45: 8-30.
2. Kolwall C, Sako K, Razack MS et ak, Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 1987; 154: 439-42.
3. Nishijima W, Takooda S, Tokita N et al. Analysis of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol 1993; 119: 65-8.
4. Hong WK, Bromer R. Chemotherapy in head and neck cancer. Current concepts. N Engl J Med 1983; 308: 75-9.
5. Lenoe LA, Albata MM, Rege VB. Treatment of carcinoma of the head and neck with intravenous methotrexate. Cancer 1968; 21: 828-37.
6. Forastiere AA, Metch B, Schuller DE et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 1992; 10: 1245-51.
7. The Liverpool Head and Neck Oncology Group. A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Br J Cancer 1990; 61: 311-5.
8. Jacobs C, Lyman G, Velez-Garcid E et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257-63.
9. Jacobs C, Meyers F, Hendrickson C et al. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer 1983; 52: 1563-9.
10. Vogl SE, Schoenfeld DA, Kaplan BH et al. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin and cisplatin in head and neck cancer. Cancer 1985; 56: 432-42.
11. Williams SD, Velez-Garcia E, Essessee I et al. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate. Cancer 1986; 57: 18-23.
12. Haraf DJ, Vokes EE, Panje WR, Weichselbaum RR. Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 1991; 14: 419-26.
13. Haraf DJ, Yokes EE, Weichselbaum RR, Panje WR. Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor prognosis head and neck cancer. Laryngoscope 1992; 102: 630-6.
14. Yokes EE, Haraf DJ, Mick R et al. Intensified concomitant chemoradiotherapy with and without filgrastim for poor prognosis head and neck cancer. J Clin Oncol 1994; 12: 2351-9.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
16. Cox DR. Regression models and lifetables. J R Stat Soc B 1972; 34: 187-220.
17. Haraf DJ, Weichselbaum RR. Treatment selection in T1 and T2 vocal cord carcinoma. Oncology 1988; 2: 41-7.
18. Sinha PP. Radiation therapy in early carcinoma of the true vocal cords, (stage I and II), Int J Radiat Oncol Biol Phys 1987; 13: 1635-40.
19. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-90.
20. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989; 158: 309-13.
21. Vandenbrouck C, Sancho-Garnier H, Chassagne D et al. Elective versus therapeutic radical neck dissection on epidermoid carcinoma of the oral cavity. Results of a randomized clinical trial. Cancer 1980; 46: 386-90.
22. Hong WK, Bronner RH, Amato DA et al. Patterns of relapse in locally advanced head and neck cancer patients who have received complete remission after combined modality treatment. Cancer 1985; 45: 1242-5.
23. Marcial VA, Pajak TF, Kramer S et al. Radiation therapy oncology group (RTOG) studies in head and neck cancer. Semin Oncol 1988; 15: 39-60.
24. Browmann GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: What we have learned from randomized trials. Semin Oncol 1994; 21: 311-9.
25. Vokes EE, Weichselbaum RR, Lippman S, Hong WK. Head and neck cancer. N Engl J Med 1993; 328: 184-94.
26. Vokes EE, Haraf DJ, Stenson K et al. The role on paclitaxel in the treatment of head and neck cancer. Semin Oncol 1995; 22: 13-7.
27. Pomp J, Levendag PC, van Putten WLJ. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 1988; 11: 543-9.
28. Emami B, Bignardi M, Devineni VR et al. Reirradiation of recurrent head and neck cancers. Laryngoscope 1987; 97: 85-8.
29. Stevens KR, Britsch A, Moss WT. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994; 29: 687-98.
30. Fu KK, Phillips TL, Silverberg IJ et al. Combined RT and CT with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-8.
31. Lo TC, Wiley AL Jr, Ansfield FJ et al. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx. A randomized study. Am J Roentgol 1976; 126: 229-35.
32. Merlano M, Corvo R, Margarino G et al. Combination chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer 1991; 67: 915-21.
33. Merlano M, Vitale V, Rosso R et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N EnglJ Med 1992; 327: 1115-21.
34. Gandia D, Wibault P, Guillot T et al. Simultaneous chemoradiotherapy as salvage treatment in local recurrences of squamous head and neck cancer. Head Neck 1993; 15: 8-15.
35. Weppelmann B, Wheeler RH, Peters GE et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea and reirradiation. Int J Radiat Oncol Biol Phys 1992; 22: 1051-6.
36. Hartsell WF, Thomas CR Jr, Murthy AK et al. Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy on regionally recurrent head and neck cancer (EST P-C385). Am J Clin Oncol 1994; 17: 338-43.